BRAK Rat

BRAK (CXCL14) Rat Recombinant
Shipped with Ice Packs
In Stock

Description

CXCL14 Rat Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.
The CXCL14 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Chemokine (C-X-C motif) ligand 14 (CXCL14), also known as BRAK (breast and kidney-expressed chemokine), is a small cytokine belonging to the CXC chemokine family. This chemokine is constitutively expressed in various tissues, including breast and kidney tissues, and plays a role in immune regulation and inflammation. CXCL14 exhibits chemotactic activity for monocytes, attracting them to sites of inflammation, but does not have a similar effect on lymphocytes, dendritic cells, neutrophils, or macrophages. Furthermore, CXCL14 has been implicated in the regulation of monocyte-derived macrophage homeostasis.
Description
Recombinant rat CXCL14, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 77 amino acids. It has a molecular mass of 9.4 kDa. The purification process of CXCL14 involves the use of proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder
Formulation
The protein was lyophilized from a 0.2 µm filtered concentrated solution in 30% Acetonitrile and 0.1% TFA.
Solubility
Reconstitute the lyophilized CXCL14 in sterile 18 MΩ-cm H2O at a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.
Stability
Lyophilized CXCL14 can be stored at room temperature for up to 3 weeks, but it is recommended to store it desiccated below -18°C for extended periods. After reconstitution, store CXCL14 at 4°C for 2-7 days. For long-term storage, it should be kept at -18°C. Avoid repeated freeze-thaw cycles.
Purity
The purity of CXCL14 is greater than 95%, as determined by: (a) RP-HPLC analysis (b) SDS-PAGE analysis
Biological Activity
The biological activity of CXCL14 is determined by its ability to induce chemotaxis in activated monocytes. This is typically measured using a concentration range of 1.0-10.0 ng/ml.
Synonyms
C-X-C motif chemokine 14, B-cell and monocyte-activating chemokine, Chemokine BRAK, Kidney-expressed chemokine CXC, MIP-2G, Small-inducible cytokine B14, Cxcl14, Bmac, Kec, Ks1, Mip2g, Scyb14, BRAK, NJAC, AI414372, bolekine, MIP2gamma, 1110031L23Rik, 1200006I23Rik.
Source
Escherichia Coli.
Amino Acid Sequence
SKCKCSRKGP KIRYSDVKKL EMKPKYPHCE EKMVIITTKS MSRYRGQEHC LHPKLQSTKR FIKWYNAWNE KRRVYEE.

Q&A

What are the taxonomic classifications and physical characteristics of BRAK Rats?

BRAK Rats belong to the genus Rattus, which includes species like Rattus rattus (black rat). The taxonomic classification is as follows:

Taxonomic RankClassification
DomainEukaryota
KingdomAnimalia
PhylumChordata
ClassMammalia
OrderRodentia
FamilyMuridae
GenusRattus
SpeciesR. rattus

A typical adult black rat measures 12.75 to 18.25 cm in length (excluding tail), with tails measuring 15 to 22 cm. They typically weigh between 75 to 230 g, depending on subspecies. Despite their name, black rats exhibit several color forms, usually black to light brown with lighter undersides. Their lifespan averages one year in the wild but can extend to four years in laboratory settings .

What are the origins and genetic characteristics of BRAK Rats?

The black rat likely originated in the Indian subcontinent but is now found worldwide. Interestingly, genetic variations exist between populations - the black rat in the Mediterranean region differs genetically from its South Asian ancestor by having 38 chromosomes instead of 42 . This chromosomal variation illustrates important genetic distinctions that researchers must consider when selecting specific rat strains for studies. Historical records indicate the black rat was present in prehistoric Europe and the Levant during postglacial periods, demonstrating its long-standing presence in these regions .

How should I determine appropriate sample sizes for BRAK Rat studies?

Sample size determination should balance statistical power with ethical considerations to minimize animal use. The integrated experimental protocol described in the literature requires 1,720 animals, which represents a reduction of up to 53% compared to using separate test protocols . When calculating sample sizes, consider:

  • Expected effect size based on preliminary data or literature

  • Desired statistical power (typically 0.8 or higher)

  • Significance level (typically α=0.05)

  • Variability in measured outcomes

  • Anticipated experimental dropout rates

  • Ethical obligations to minimize animal use

How can researchers implement integrated experimental designs for comprehensive toxicological assessment using BRAK Rats?

Researchers can adopt an integrated study design based on a stepwise process that includes priority endpoints from established guidelines. This approach enables assessment of multiple toxicological endpoints including developmental exposures and long-term outcomes within a single protocol . Key components include:

  • Designing protocols that capture chronic toxicity, carcinogenicity, and developmental/reproductive toxicity effects

  • Incorporating multiple windows of susceptibility (prenatal, lactational, neonatal exposures)

  • Evaluating outcomes over the complete lifespan

  • Using the same generational cohort for multiple assessments

  • Including satellite parallel experiments to measure biomarkers and system-specific responses

This integrated approach optimizes animal use in accordance with the 3Rs (replacement, reduction, and refinement) while generating comprehensive data for risk assessment and public health decision-making .

What role do familiarity and social factors play in behavioral studies using different rat strains?

Professor Mason's research revealed profound implications of familiarity on rat behavior. Her experiments demonstrated that:

  • White laboratory rats exhibited empathetic rescue behavior toward familiar rats trapped in containers

  • Initially, white rats did not rescue unfamiliar black rats placed in the same traps

  • After cohabitation periods that established familiarity, white rats rescued black rats

  • White rats raised exclusively among black rats did not recognize or rescue unfamiliar white rats, despite genetic similarity

These findings suggest that social familiarity overrides genetic factors in determining empathetic responses. Researchers must carefully control for familiarity variables when designing behavioral experiments using multiple rat strains. Early rearing conditions significantly impact behavioral outcomes, which could confound results if not properly accounted for in experimental design .

How should researchers address the challenges of integrating multiple toxicological endpoints in BRAK Rat studies?

The integration of multiple toxicological endpoints presents several challenges that researchers must address systematically:

  • Endpoint Interference: Ensure that measurements for one endpoint don't interfere with assessments for others. Design experiments where satellite groups can be used for specialized assessments without compromising the main cohort.

  • Temporal Coordination: Carefully plan the timing of different assessments to prevent stress from one procedure affecting results in subsequent tests.

  • Statistical Considerations: Account for multiple comparisons when analyzing diverse endpoints to control false discovery rates.

  • Resource Optimization: As described in the literature, an integrated design can reduce animal use by up to 53% compared to separate protocols, but requires meticulous coordination of resources and personnel .

  • Data Integration: Develop frameworks for integrating findings across different biological systems and timepoints to build comprehensive understanding of toxicological mechanisms.

What approaches are most effective for studying developmental neurotoxicity in BRAK Rat models?

Effective developmental neurotoxicity assessment in rat models requires comprehensive approaches:

  • Critical Windows Exposure: Target exposures during key neurodevelopmental periods (prenatal, early postnatal, adolescence)

  • Tiered Assessment Strategy: Begin with behavioral screening (motor activity, learning and memory, social behavior) followed by targeted mechanistic investigations

  • Integrated Endpoints: Combine behavioral assessments with neuroanatomical, neurochemical, and molecular analyses

  • Longitudinal Design: Track neurodevelopmental outcomes across the lifespan to identify delayed or progressive effects

  • Mechanistic Biomarkers: Incorporate measurements of neural cell development, synaptogenesis, myelination, and neuroinflammatory responses

The integrated experimental design approach described in the literature provides a framework for comprehensive assessment by allowing the same generational cohort to be monitored for both developmental exposures and long-term neurodevelopmental outcomes .

What are the optimal methods for tissue collection and preservation in BRAK Rat toxicological studies?

Optimal tissue collection and preservation methods depend on the specific analyses planned:

  • Timing Considerations: Standardize collection times relative to circadian rhythms and last feeding to minimize variability

  • Non-Terminal Sampling: For longitudinal studies, employ techniques that allow repeated sampling from the same animal (e.g., tail vein blood collection)

  • Preservation Techniques:

    • For histopathology: 10% neutral buffered formalin followed by paraffin embedding

    • For molecular analyses: Flash freezing in liquid nitrogen followed by -80°C storage

    • For electron microscopy: Glutaraldehyde fixation

  • Sample Processing: Establish standardized protocols for immediate processing steps (centrifugation, aliquoting, etc.)

  • Quality Control: Include procedural controls and validation steps to ensure sample integrity throughout collection, processing, and storage

As described in the integrated experimental design approach, careful coordination of sampling protocols is essential when multiple endpoints are being assessed in the same study .

How should researchers analyze and interpret data from multi-endpoint BRAK Rat studies?

Analysis of multi-endpoint studies requires sophisticated statistical approaches:

  • Mixed-Effects Modeling: Account for repeated measures and nested data structures when analyzing longitudinal data

  • Multiple Comparison Adjustments: Apply methods such as Bonferroni correction or false discovery rate control when analyzing multiple endpoints

  • Integration Frameworks: Utilize adverse outcome pathway (AOP) frameworks to connect molecular initiating events to adverse outcomes at the organism level

  • Benchmark Dose Modeling: Establish dose-response relationships and points of departure for risk assessment

  • Weight-of-Evidence Approach: Integrate findings across endpoints to develop a comprehensive understanding of toxicological mechanisms

  • Sensitivity Analysis: Identify which endpoints are most sensitive to detect effects at the lowest doses

What quality control measures are essential when working with BRAK Rat models?

Essential quality control measures include:

  • Genetic Authentication: Regularly verify the genetic integrity of rat colonies to prevent genetic drift or contamination

  • Health Monitoring: Implement comprehensive health surveillance programs to detect pathogen introduction

  • Environmental Monitoring: Continuously track housing conditions (temperature, humidity, light cycles) to ensure consistency

  • Dietary Control: Use standardized, batch-controlled diets with certificates of analysis

  • Procedural Standardization: Develop and validate standard operating procedures for all experimental techniques

  • Blinded Assessment: Ensure personnel conducting assessments are blinded to treatment groups whenever possible

  • Inter-observer Reliability: For subjective measurements, assess and report agreement between multiple trained observers

  • Data Verification: Implement systems for independent verification of critical data points

These measures help minimize experimental variability and enhance reproducibility, which is particularly important in integrated studies where multiple endpoints are being assessed .

How can researchers identify and analyze chemical constituents and metabolites in BRAK Rat serum?

Advanced analytical techniques for identifying chemical constituents and metabolites in rat serum include:

  • Liquid Chromatography-Mass Spectrometry (LC-MS): Provides high-sensitivity detection and identification of compounds in complex biological matrices

  • Gas Chromatography-Mass Spectrometry (GC-MS): Suitable for volatile and semi-volatile compounds

  • Nuclear Magnetic Resonance (NMR) Spectroscopy: Offers structural information and quantification without compound destruction

  • Metabolomics Approaches: Untargeted screening to identify novel metabolites and metabolic pathways

  • Pharmacokinetic Modeling: Mathematical modeling to understand absorption, distribution, metabolism, and excretion

These techniques can help identify bioactive compounds, understand their metabolism, and establish pharmacodynamic relationships, as mentioned in research on analyzing rat serum following exposure to complex compounds .

How can findings from BRAK Rat studies be effectively translated to human health risk assessment?

Translating rat study findings to human health risk assessment requires systematic consideration of:

The integrated experimental design approach provides comprehensive data across multiple endpoints and life stages, strengthening the scientific basis for human health extrapolation .

What are the most significant challenges in reproducing BRAK Rat study results across different laboratories?

Significant challenges in reproducing rat study results across laboratories include:

  • Strain Differences: Subtle genetic differences between colonies of nominally the same strain

  • Environmental Variables: Variations in housing conditions, noise levels, handling procedures, and microbial environments

  • Procedural Variations: Differences in experimental protocols, sample collection methods, and analytical techniques

  • Observer Effects: Variability in scoring of subjective endpoints by different researchers

  • Temporal Factors: Circadian and seasonal influences on physiological parameters

  • Reporting Bias: Incomplete reporting of methodological details critical for reproduction

  • Social Factors: As demonstrated in Professor Mason's research, social familiarity significantly impacts behavior, yet housing and socialization protocols often differ between laboratories

Addressing these challenges requires comprehensive reporting of methods, standardized protocols, and consideration of both biological and environmental variables that might influence experimental outcomes.

How should contradictory results between different BRAK Rat studies be reconciled?

When faced with contradictory results between studies, researchers should:

How can researchers balance comprehensive toxicological assessment with ethical considerations in BRAK Rat studies?

Balancing comprehensive assessment with ethical considerations involves:

  • 3Rs Implementation: Apply replacement, reduction, and refinement principles in study design

  • Integrated Study Design: As described in the literature, integrated protocols can reduce animal use by up to 53% compared to separate test protocols while still generating comprehensive data

  • Statistical Optimization: Use power analyses to determine minimum necessary sample sizes

  • Humane Endpoints: Establish clear criteria for intervention or euthanasia to minimize suffering

  • Non-Invasive Technologies: Incorporate imaging and biomonitoring techniques that allow longitudinal assessment without terminal procedures

  • Tissue Sharing: Maximize information obtained from each animal through coordinated tissue collection and sharing

  • Pilot Studies: Conduct small-scale pilot studies to refine protocols before proceeding to full-scale investigations

What are the key regulatory considerations when designing BRAK Rat studies for safety assessment?

Key regulatory considerations include:

  • Guideline Alignment: Design studies to meet requirements of relevant regulatory guidelines (e.g., OECD, EPA, FDA)

  • GLP Compliance: Implement Good Laboratory Practice standards when conducting studies intended for regulatory submission

  • Validation Requirements: Ensure methods used for critical endpoints are validated according to regulatory standards

  • Historical Control Considerations: Maintain robust historical control databases for contextualizing findings

  • Reporting Standards: Adhere to comprehensive reporting requirements specified by regulatory agencies

  • Integrated Testing Strategies: Consider how the integrated experimental design approach can be adapted to meet regulatory requirements while reducing animal use

  • Emerging Methodologies: Stay informed about regulatory acceptance of new approach methodologies that may complement or partially replace traditional animal testing

Aligning study designs with both scientific best practices and regulatory requirements ensures that findings will contribute meaningfully to safety assessment and regulatory decision-making.

Product Science Overview

Structure and Expression

The CXCL14 gene encodes a precursor protein consisting of 99 amino acids, which includes a 22 amino acid signal peptide that is cleaved to produce the mature 77 amino acid protein . The mature protein has a calculated molecular weight of approximately 9.4 kDa . Four conserved cysteines in the mature protein form two intrachain disulfide bonds, which are crucial for its structural stability .

CXCL14 is expressed in a wide range of tissues, including the breast, kidney, and other normal tissues . It is known for its chemotactic activity, particularly for monocytes, but not for B and T cells .

Biological Functions

CXCL14 plays a significant role in various biological processes:

  1. Chemotaxis: CXCL14 exhibits chemotactic activity for monocytes and monocyte-derived dendritic cells and natural killer cells . This makes it an important player in the immune response.
  2. Tumor Suppression: Recent studies have highlighted the role of CXCL14 in tumor suppression. It has been shown to inhibit tumorigenesis and motility, making it a potential therapeutic candidate for cancer treatment .
  3. Metabolism: CXCL14 is also involved in fat metabolism modulation, which could have implications for obesity and related metabolic disorders .
Recombinant Production

Recombinant CXCL14 can be produced in various expression systems, with Escherichia coli being a common choice due to its simplicity and cost-effectiveness . The recombinant protein is typically purified using techniques such as nickel affinity chromatography and ion exchange chromatography to achieve high purity and bioactivity . The endotoxin level in the purified protein is kept low to ensure its safety for in vivo studies .

Applications

Recombinant CXCL14 has several applications in research and therapeutic development:

  • Cancer Research: Due to its tumor-suppressive properties, CXCL14 is being studied as a potential therapeutic agent for cancer treatment.
  • Immunology: Its role in chemotaxis makes it a valuable tool for studying immune cell migration and function.
  • Metabolic Studies: CXCL14’s involvement in fat metabolism makes it a candidate for research into obesity and metabolic disorders.

In summary, BRAK (CXCL14) (Rat Recombinant) is a versatile and biologically significant chemokine with potential applications in cancer therapy, immunology, and metabolic research. Its recombinant production allows for extensive study and potential therapeutic use.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.